Vanguard Group’s Actinium Pharmaceuticals ATNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.92M Sell
1,371,840
-199,924
-13% -$280K ﹤0.01% 3544
2025
Q1
$2.53M Sell
1,571,764
-45,608
-3% -$73.4K ﹤0.01% 3414
2024
Q4
$2.04M Sell
1,617,372
-7,628
-0.5% -$9.61K ﹤0.01% 3561
2024
Q3
$3.06M Buy
1,625,000
+145,790
+10% +$274K ﹤0.01% 3434
2024
Q2
$10.9M Buy
1,479,210
+32,884
+2% +$243K ﹤0.01% 2862
2024
Q1
$11.3M Buy
1,446,326
+82,113
+6% +$643K ﹤0.01% 2888
2023
Q4
$6.93M Buy
1,364,213
+22,664
+2% +$115K ﹤0.01% 3144
2023
Q3
$7.94M Buy
1,341,549
+7,267
+0.5% +$43K ﹤0.01% 3019
2023
Q2
$9.9M Buy
1,334,282
+50,382
+4% +$374K ﹤0.01% 2945
2023
Q1
$12.1M Buy
1,283,900
+166,849
+15% +$1.58M ﹤0.01% 2834
2022
Q4
$11.9M Buy
1,117,051
+48,104
+5% +$512K ﹤0.01% 2875
2022
Q3
$7.89M Hold
1,068,947
﹤0.01% 3078
2022
Q2
$5.14M Buy
1,068,947
+210,110
+24% +$1.01M ﹤0.01% 3366
2022
Q1
$4.39M Sell
858,837
-6,752
-0.8% -$34.5K ﹤0.01% 3596
2021
Q4
$5.2M Sell
865,589
-1,142
-0.1% -$6.86K ﹤0.01% 3589
2021
Q3
$7.68M Buy
866,731
+47,089
+6% +$417K ﹤0.01% 3399
2021
Q2
$6.48M Buy
819,642
+247,122
+43% +$1.95M ﹤0.01% 3448
2021
Q1
$4.36M Buy
572,520
+13,740
+2% +$105K ﹤0.01% 3600
2020
Q4
$4.36M Buy
558,780
+54,285
+11% +$423K ﹤0.01% 3423
2020
Q3
$4.89M Buy
504,495
+10,313
+2% +$99.9K ﹤0.01% 3158
2020
Q2
$5.21M Buy
494,182
+342,537
+226% +$3.61M ﹤0.01% 3082
2020
Q1
$883K Sell
151,645
-3,249
-2% -$18.9K ﹤0.01% 3526
2019
Q4
$1.01M Hold
154,894
﹤0.01% 3637
2019
Q3
$1.07M Buy
154,894
+54,018
+54% +$373K ﹤0.01% 3635
2019
Q2
$745K Sell
100,876
-51,068
-34% -$377K ﹤0.01% 3750
2019
Q1
$2.19M Buy
151,944
+40,776
+37% +$587K ﹤0.01% 3419
2018
Q4
$1.29M Buy
111,168
+25,310
+29% +$294K ﹤0.01% 3490
2018
Q3
$1.91M Buy
85,858
+5,146
+6% +$114K ﹤0.01% 3549
2018
Q2
$1.55M Sell
80,712
-2,064
-2% -$39.6K ﹤0.01% 3568
2018
Q1
$907K Sell
82,776
-299
-0.4% -$3.28K ﹤0.01% 3666
2017
Q4
$1.65M Buy
83,075
+11,431
+16% +$228K ﹤0.01% 3483
2017
Q3
$1.24M Buy
71,644
+186
+0.3% +$3.21K ﹤0.01% 3536
2017
Q2
$2.62M Buy
71,458
+4,952
+7% +$181K ﹤0.01% 3302
2017
Q1
$3.01M Buy
66,506
+15,331
+30% +$694K ﹤0.01% 3248
2016
Q4
$1.34M Sell
51,175
-4,548
-8% -$119K ﹤0.01% 3487
2016
Q3
$2.26M Buy
55,723
+3,015
+6% +$122K ﹤0.01% 3339
2016
Q2
$2.8M Buy
52,708
+8,478
+19% +$450K ﹤0.01% 3238
2016
Q1
$2.64M Buy
44,230
+6,559
+17% +$392K ﹤0.01% 3269
2015
Q4
$3.65M Buy
37,671
+6,043
+19% +$586K ﹤0.01% 3129
2015
Q3
$1.68M Buy
31,628
+3,847
+14% +$204K ﹤0.01% 3452
2015
Q2
$2.21M Buy
27,781
+1,957
+8% +$156K ﹤0.01% 3369
2015
Q1
$1.91M Buy
25,824
+8,118
+46% +$601K ﹤0.01% 3435
2014
Q4
$3.13M Buy
17,706
+626
+4% +$111K ﹤0.01% 3109
2014
Q3
$3.43M Buy
17,080
+998
+6% +$201K ﹤0.01% 3033
2014
Q2
$3.48M Buy
+16,082
New +$3.48M ﹤0.01% 3012